Atea Pharmaceuticals, Inc. (AVIR)
5.45
-0.06
(-1.09%)
USD |
NASDAQ |
Aug 27, 16:00
5.42
-0.03
(-0.55%)
After-Hours: 17:20
Atea Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2021 | 60.95% |
| September 30, 2021 | -85.93% |
| June 30, 2021 | 2.55% |
| Date | Value |
|---|---|
| March 31, 2021 | 46.55% |
| December 31, 2020 | 42.47% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | -- |
| CorMedix, Inc. | 25.50% |
| Eloxx Pharmaceuticals, Inc. | -- |
| Cannabis Global, Inc. | -- |
| Breakthrough Chemistry, Inc. | -43.31K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -59.31% |
| Return on Assets | -53.35% |
| Return on Invested Capital | -59.13% |
| Return on Net Operating Assets | -15.17K% |